Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

This article is the first in a 2-part series that summarizes the proceedings from a roundtable meeting that was conducted to discuss real-world considerations in nonvalvular atrial fibrillation and venous thromboembolism.

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Trending on AJMC

Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol

Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD

Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment

Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD

Striking a Balance: Innovation, Affordability, and Equitable Access in Cancer Care